JP2015527408A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015527408A5 JP2015527408A5 JP2015531321A JP2015531321A JP2015527408A5 JP 2015527408 A5 JP2015527408 A5 JP 2015527408A5 JP 2015531321 A JP2015531321 A JP 2015531321A JP 2015531321 A JP2015531321 A JP 2015531321A JP 2015527408 A5 JP2015527408 A5 JP 2015527408A5
- Authority
- JP
- Japan
- Prior art keywords
- hmb
- atp
- composition
- animal
- improving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AXFYFNCPONWUHW-UHFFFAOYSA-N 3-hydroxyisovaleric acid Chemical compound CC(C)(O)CC(O)=O AXFYFNCPONWUHW-UHFFFAOYSA-N 0.000 claims description 54
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 claims description 22
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 claims description 22
- 241001465754 Metazoa Species 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 15
- 210000003205 muscle Anatomy 0.000 claims description 6
- 230000007423 decrease Effects 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 238000013270 controlled release Methods 0.000 claims description 2
- -1 elixirs Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 238000007918 intramuscular administration Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 150000003839 salts Chemical group 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000699 topical effect Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 description 15
- 230000000116 mitigating effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261698919P | 2012-09-10 | 2012-09-10 | |
| US61/698,919 | 2012-09-10 | ||
| PCT/US2013/059039 WO2014040067A1 (en) | 2012-09-10 | 2013-09-10 | Composition of hmb and atp and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015527408A JP2015527408A (ja) | 2015-09-17 |
| JP2015527408A5 true JP2015527408A5 (https=) | 2016-11-04 |
| JP6258943B2 JP6258943B2 (ja) | 2018-01-10 |
Family
ID=50237697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015531321A Active JP6258943B2 (ja) | 2012-09-10 | 2013-09-10 | Ｈｍｂおよびａｔｐの組成物ならびに使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10092590B2 (https=) |
| EP (2) | EP3733171B1 (https=) |
| JP (1) | JP6258943B2 (https=) |
| CN (1) | CN105025891B (https=) |
| AU (1) | AU2013312113B2 (https=) |
| BR (1) | BR112015005199B1 (https=) |
| CA (1) | CA2884405C (https=) |
| DK (1) | DK3733171T3 (https=) |
| ES (1) | ES2970283T3 (https=) |
| FI (1) | FI3733171T3 (https=) |
| HU (1) | HUE065064T2 (https=) |
| PL (1) | PL3733171T3 (https=) |
| PT (1) | PT3733171T (https=) |
| WO (1) | WO2014040067A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017205673A1 (en) * | 2016-05-25 | 2017-11-30 | TSI Group Ltd. | Stabilization of beta-hydroxyisovaleric acid formulations in soft gel capsules |
| US10888576B2 (en) * | 2018-10-08 | 2021-01-12 | Metabolic Technologies, Inc. | Composition of HMB and ATP and methods of use |
| JP2024524288A (ja) * | 2021-06-22 | 2024-07-05 | ティエスアイ ユーエスエイ エルエルシー | アデノシン三リン酸（ａｔｐ）を含む組成物および認知機能に対する使用方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028440A (en) | 1990-01-30 | 1991-07-02 | Iowa State University Research Foundation, Inc. | Method of raising meat producing animals to increase lean tissue development |
| US4992470A (en) | 1990-02-08 | 1991-02-12 | Iowa State University Research Foundation, Inc. | Method of enhancing immune response of mammals |
| ES2142353T3 (es) | 1992-09-16 | 2000-04-16 | Univ Iowa State Res Found Inc | Procedimiento para reducir los niveles de colesterol total y de colesterol asociado a lipoproteinas de baja densidad en sangre. |
| US5348979A (en) | 1992-12-23 | 1994-09-20 | Iowa State University Research Foundation Inc. | Method of promoting nitrogen retention in humans |
| US6031000A (en) | 1998-06-23 | 2000-02-29 | Iowa State University Research Foundation, Inc. | Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use |
| JP4010390B2 (ja) | 1999-09-20 | 2007-11-21 | 明治乳業株式会社 | 免疫賦活化組成物 |
| US7629329B2 (en) * | 2001-06-04 | 2009-12-08 | Tsi Health Sciences, Inc. | Method for increasing muscle mass and strength through administration of adenosine triphosphate |
| US20050027005A1 (en) | 2003-08-02 | 2005-02-03 | Matthias Boldt | Nutrient compositions and methods for sustenance and promotion of positive metabolic energy levels in a targeted manner |
| US20050215640A1 (en) * | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
| US20060083793A1 (en) * | 2004-09-29 | 2006-04-20 | Gardiner Paul T | Nutritional composition for promoting muscle performance and acting as hydrogen (H+) blocker |
| US20060073891A1 (en) * | 2004-10-01 | 2006-04-06 | Holt Timothy M | Display with multiple user privacy |
| JP5032310B2 (ja) * | 2005-05-27 | 2012-09-26 | 興和株式会社 | 疲労回復のための医薬 |
| WO2007108071A1 (ja) * | 2006-03-17 | 2007-09-27 | Pharma Foods International Co., Ltd. | 抗ストレス組成物及びそれを含有する飲食品 |
| WO2010068696A1 (en) | 2008-12-09 | 2010-06-17 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
| DE102009052640A1 (de) | 2009-11-10 | 2011-05-12 | Linde-Lkca-Dresden Gmbh | Verfahren und Vorrichtung zur Gaswäsche |
| EP2512236B1 (en) * | 2009-12-18 | 2016-10-19 | Metabolic Technologies, Inc. | Improved method of administering beta-hydroxy-beta-methylbutyrate (hmb) |
-
2013
- 2013-09-10 US US14/023,162 patent/US10092590B2/en active Active
- 2013-09-10 WO PCT/US2013/059039 patent/WO2014040067A1/en not_active Ceased
- 2013-09-10 BR BR112015005199-5A patent/BR112015005199B1/pt active IP Right Grant
- 2013-09-10 ES ES20169493T patent/ES2970283T3/es active Active
- 2013-09-10 HU HUE20169493A patent/HUE065064T2/hu unknown
- 2013-09-10 PL PL20169493.2T patent/PL3733171T3/pl unknown
- 2013-09-10 JP JP2015531321A patent/JP6258943B2/ja active Active
- 2013-09-10 CN CN201380058560.6A patent/CN105025891B/zh active Active
- 2013-09-10 CA CA2884405A patent/CA2884405C/en active Active
- 2013-09-10 FI FIEP20169493.2T patent/FI3733171T3/fi active
- 2013-09-10 AU AU2013312113A patent/AU2013312113B2/en active Active
- 2013-09-10 PT PT201694932T patent/PT3733171T/pt unknown
- 2013-09-10 DK DK20169493.2T patent/DK3733171T3/da active
- 2013-09-10 EP EP20169493.2A patent/EP3733171B1/en active Active
- 2013-09-10 EP EP13835631.6A patent/EP2892522A4/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012144574A5 (https=) | ||
| JP2013509429A5 (https=) | ||
| JP2013518107A5 (https=) | ||
| JP2015078230A5 (https=) | ||
| JP2014218522A5 (https=) | ||
| MY181159A (en) | Sublingual and buccal film compositions | |
| JP2012021005A5 (https=) | ||
| AR090456A1 (es) | Combinaciones farmaceuticas que comprenden un analogo de tionucleotidos | |
| JP2012193216A5 (https=) | ||
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| MX349106B (es) | Forma de dosificacion solida oral que contiene nanoparticulas y proceso para su formulacion utilizando gelatina de pescado. | |
| JP2013542261A5 (https=) | ||
| JP2013537905A5 (https=) | ||
| JP2015525763A5 (https=) | ||
| JP2011527299A5 (https=) | ||
| NZ718514A (en) | Compounds, compositions and methods useful for cholesterol mobilisation | |
| JP2016530291A5 (https=) | ||
| JP2015510916A5 (https=) | ||
| JP2012533559A5 (https=) | ||
| JP2015514739A5 (https=) | ||
| JP2015527408A5 (https=) | ||
| JP2018524306A5 (https=) | ||
| CY1124635T1 (el) | Ξηρες φαρμακευτικες συνθεσεις που περιεχουν νανοσωματιδια ενεργου παραγοντα δεσμευμενα σε σωματιδια φορεα | |
| JP2016515550A5 (https=) | ||
| WO2014052780A3 (en) | Compositions and methods of use of an inappetance-controlling compound |